Details for 2015709394
Up to date per 03.04.2026
Actions
Details for 2015709394
Granted/Registered
European Patent
28.12.2016 A
07.10.2020 B1
21.02.2014
US
201461943262 P
28.02.2014
US
201461946480 P
23.12.2014
US
201462096468 P
A61K 9/00 20060101AFI20200403BHEP
Owner
Principia Biopharma Inc.220 E. Grand Ave. S. San Francisco, CA 94080US
Representative
No representatives present
Inventor
MASJEDIZADEH, Mohammad Reza5341 Elrose Ave. San Jose, California 95124US
GOURLAY, Steven25 Henry Street Queens Park NSW 2022AU
Information about Fees